Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy July 2022 Learn more
Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty May 2022 Learn more